Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Terminated2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (28.6%)
N/A5 (71.4%)

Trials by Status

completed450%
terminated225%
unknown113%
withdrawn113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8